These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24339954)

  • 21. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
    Zhou L; Zhag G; Tang T; Lian R; Wang W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
    Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
    Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
    Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
    Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Pikoulis E; Petrou A; Agrogiannis G; Petrides C; Papakonstandinou I; Papalambros A; Aggelou A; Kavatzas N; Liakakos T; Felekouras E
    Sci Rep; 2017 May; 7(1):2058. PubMed ID: 28515480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-institutional analysis of 429 patients undergoing major hepatectomy for colorectal cancer liver metastases: The impact of concomitant bile duct resection on survival.
    Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RC; Winslow ER; Maithel SK
    J Surg Oncol; 2015 Oct; 112(5):524-8. PubMed ID: 26496211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.
    Beamish P; Lemke M; Li J; Dixon E; Abraham MT; Hernandez-Alejandro R; Bennett S; Martel G; Karanicolas PJ;
    HPB (Oxford); 2017 Aug; 19(8):675-681. PubMed ID: 28495435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of KRAS mutation with primary tumor location and survival in patients undergoing resection of colorectal cancers and synchronous liver metastases.
    Allievi N; Goffredo P; Utria AF; Pisano M; Poiasina E; Lucianetti A; Zhou P; Hassan I
    Chin Clin Oncol; 2019 Oct; 8(5):46. PubMed ID: 31500429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases.
    Jarnagin WR; Conlon K; Bodniewicz J; Dougherty E; DeMatteo RP; Blumgart LH; Fong Y
    Cancer; 2001 Mar; 91(6):1121-8. PubMed ID: 11267957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
    Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
    World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E
    Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.
    Acciuffi S; Meyer F; Bauschke A; Settmacher U; Lippert H; Croner R; Altendorf-Hofmann A
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):593-599. PubMed ID: 29340767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma.
    Imamura H; Matsuyama Y; Shimada R; Kubota M; Nakayama A; Kobayashi A; Kitamura H; Ikegami T; Miyagawa SI; Kawasaki S
    Am J Gastroenterol; 2001 Nov; 96(11):3178-84. PubMed ID: 11721768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    Konishi T; Yoshidome H; Shida T; Furukawa K; Takayashiki T; Kuboki S; Takano S; Miyazaki M; Ohtsuka M
    J Surg Oncol; 2021 Sep; 124(4):598-606. PubMed ID: 34061356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
    Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors.
    Nagashima I; Takada T; Adachi M; Nagawa H; Muto T; Okinaga K
    World J Gastroenterol; 2006 Oct; 12(39):6305-9. PubMed ID: 17072953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.